AtriCure (ATRC) Net Cash Flow (2010 - 2026)

AtriCure (ATRC) has reported Net Cash Flow for 17 consecutive years, with $21.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 24.83% year-over-year to $21.7 million in Q2 2026; TTM through Jun 2026 was $50.2 million, a 344.83% increase from a year earlier, with the FY2025 full-year figure at $44.0 million, up 13.2% from the prior year.
• Net Cash Flow was $21.7 million for Q2 2026 at AtriCure, up from -$21.1 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $41.1 million in Q2 2024 and troughed at -$23.0 million in Q1 2025.
• A 5-year average of $6.9 million and a median of $11.3 million in 2022 frame the typical range for Net Cash Flow.
• The widest YoY moves for Net Cash Flow: up 508.19% in 2024, down 297.59% in 2024.
• Over 5 years, Net Cash Flow stood at $9.0 million in 2022, then tumbled by 60.1% to $3.6 million in 2023, then tumbled by 297.59% to -$7.1 million in 2024, then surged by 374.24% to $19.5 million in 2025, then rose by 11.09% to $21.7 million in 2026.
• The last three Net Cash Flow figures came in at $21.7 million (Q2 2026), -$21.1 million (Q1 2026), and $19.5 million (Q4 2025), per Business Quant data.